Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway

Kleiner, 2005, Design and validation of a histoloical scoring system for nonalcoholic fatty liver disease, Hepatology, 411, 313

Michelotti, 2013, NAFLD, NASH and liver cancer, Nat Rev Gastroenterol Hepatol, 10, 656, 10.1038/nrgastro.2013.183

Byrne, 2015, NAFLD: a multisystem disease, J Hepatol, 62, S47, 10.1016/j.jhep.2014.12.012

Zhu, 2016, Fatty liver diseases, bile acids, and FXR, Acta Pharm Sin B, 6, 409, 10.1016/j.apsb.2016.07.008

Nascimbeni, 2013, From NAFLD in clinical practice to answers from guidelines, J Hepatol, 59, 859, 10.1016/j.jhep.2013.05.044

Labrecque, 2014, World Gastroenterology Organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, J Clin Gastroenterol, 48, 467, 10.1097/MCG.0000000000000116

Carazo, 2011, Hepatic expression of adiponectin receptors increases with non-alcoholic fatty liver disease progression in morbid obesity in correlation with glutathione peroxidase 1, Obes Surg, 21, 492, 10.1007/s11695-010-0353-2

Zhang, 2016, Effects of moderate and vigorous exercise on nonalcoholic fatty liver disease: a randomized clinical trial, JAMA Intern Med, 176, 1074, 10.1001/jamainternmed.2016.3202

Boschbarrera, 2015, Silibinin and STAT3: a natural way of targeting transcription factors for cancer therapy, Cancer Treat Rev, 41, 540, 10.1016/j.ctrv.2015.04.008

Muthumani, 2012, Silibinin potentially protects arsenic-induced oxidative hepatic dysfunction in rats, Toxicol Mech Methods, 22, 277, 10.3109/15376516.2011.647113

Zhang, 2013, Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway, Int Immunopharmacol, 17, 714, 10.1016/j.intimp.2013.08.019

Haddad, 2011, Antioxidant and hepatoprotective effects of silibinin in a rat model of nonalcoholic steatohepatitis, Evid Based Complement Alternat Med, nep164

Serviddio, 2010, A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis, J Pharmacol Exp Ther, 332, 922, 10.1124/jpet.109.161612

Loguercio, 2012, Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial, Free Radic Biol Med, 52, 1658, 10.1016/j.freeradbiomed.2012.02.008

Wang, 2017, Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates, Nat Med, 23, 439, 10.1038/nm.4290

Cheng, 2017, MicroRNA-199a-3p attenuates hepatic lipogenesis by targeting Sp1, Am J Transl Res, 9, 1905

Chen, 2017, Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPARα/AdipoR2, in vivo and in vitro, Biomed Pharmacother, 91, 621, 10.1016/j.biopha.2017.04.125

Zheng, 2014, Differential metabolism of 4-hydroxynonenal in liver, lung and brain of mice and rats, Toxicol Appl Pharmacol, 279, 43, 10.1016/j.taap.2014.04.026

Liang, 2013, MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis, J Hepatol, 58, 535, 10.1016/j.jhep.2012.10.024

Flores-Costa, 2017, The soluble guanylate cyclase stimulator IW-1973 prevents inflammation and fibrosis in experimental non-alcoholic steatohepatitis, Br J Pharmacol, 175, 953, 10.1111/bph.14137

Krawczyk, 2010, Nonalcoholic fatty liver disease, Best Pract Res Clin Gastroenterol, 24, 695, 10.1016/j.bpg.2010.08.005

Day, 2002, Non-alcoholic steatohepatitis: definitions and pathogenesis, J Gastroenterol Hepatol, 17, S377, 10.1046/j.1440-1746.17.s3.31.x

Schattenberg, 2011, Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo, J Hepatol, 55, 1272, 10.1016/j.jhep.2011.03.008

Kohl, 2013, Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cells, Cell Death Dis, 4, e712, 10.1038/cddis.2013.228

Schattenberg, 2012, Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP, Am J Physiol Gastrointest Liver Physiol, 303, G498, 10.1152/ajpgi.00525.2011

Cong, 2008, The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice, Life Sci, 82, 983, 10.1016/j.lfs.2008.01.022

Seo, 2008, PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes, J Gastroenterol Hepatol, 23, 102, 10.1111/j.1440-1746.2006.04819.x

Forcheron, 2002, Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients, Diabetes, 51, 3486, 10.2337/diabetes.51.12.3486

Wang, 2016, Protective effects of glycyrrhizic acid from edible botanical Glycyrrhiza glabra against non-alcoholic steatohepatitis in mice, Food Funct, 7, 3716, 10.1039/C6FO00773B

Furuhashi, 2008, Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets, Nat Rev Drug Discov, 7, 489, 10.1038/nrd2589

Ntambi, 2004, Regulation of stearoyl-CoA desaturases and role in metabolism, Prog Lipid Res, 43, 91, 10.1016/S0163-7827(03)00039-0

Cao, 2006, Molecular identification of microsomal acyl-CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesis, Proc Natl Acad Sci U S A, 103, 19695, 10.1073/pnas.0609140103

Lettéron, 2003, Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice, Hepatology, 38, 133, 10.1053/jhep.2003.50309

Rizki, 2006, Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1, J Lipid Res, 47, 2280, 10.1194/jlr.M600198-JLR200

Chang, 2010, Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats, J Lipid Res, 51, 2504, 10.1194/jlr.M001958

Zhang, 2012, Dietary sea cucumber cerebroside alleviates orotic acid-induced excess hepatic adipopexis in rats, Lipids Health Dis, 11, 48, 10.1186/1476-511X-11-48

Wetterau, 1992, Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia, Science, 258, 999, 10.1126/science.1439810

Kawano, 2013, Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease, J Gastroenterol, 48, 434, 10.1007/s00535-013-0758-5

Rinella, 2015, Nonalcoholic fatty liver disease: a systematic review, J Am Med Assoc, 313, 2263, 10.1001/jama.2015.5370

Chen, 2017, Hydrogen sulphide treatment increases insulin sensitivity and improves oxidant metabolism through the CaMKKβ-AMPK pathway in PA-induced IR C2C12 cells, Sci Rep, 7, 13248, 10.1038/s41598-017-13251-0

Li, 2018, Polyphenol stilbenes from fenugreek (Trigonella foenum-graecum L.) seeds improve insulin sensitivity and mitochondrial function in 3T3-L1 adipocytes, Oxid Med Cell Longev, 2018, 7634362, 10.1155/2018/7634362

Zhu, 2016, Neutral ceramidase-enriched exosomes prevent palmitic acid-induced insulin resistance in H4IIEC3 hepatocytes, FEBS Open Bio, 6, 1078, 10.1002/2211-5463.12125

Aguirre, 2002, Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action, J Biol Chem, 277, 1531, 10.1074/jbc.M101521200

Yesilova, 2005, Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease, Am J Gastroenterol, 100, 850, 10.1111/j.1572-0241.2005.41500.x

Vomund, 2017, Nrf2, the master regulator of anti-oxidative responses, Int J Mol Sci, 18, pii: E2772, 10.3390/ijms18122772

Lee, 2017, Melaleuca alternifolia induces heme oxygenase-1 expression in murine RAW264.7 cells through activation of the Nrf2-ARE pathway, Am J Chin Med, 45, 1631, 10.1142/S0192415X17500884

Yin, 2017, Chinese herbal medicine compound Yi-Zhi-Hao pellet inhibits replication of influenza virus infection through activation of heme oxygenase-1, Acta Pharm Sin B, 7, 630, 10.1016/j.apsb.2017.05.006

Zeng, 2017, Schisandra sphenanthera extract protects against chronic-binge and acute alcohol-induced liver injury by regulating the NRF2-ARE pathway in mice, Acta Pharm Sin B, 7, 583, 10.1016/j.apsb.2017.04.002

Park, 2018, Hepatocyte-specific clusterin overexpression attenuates diet-induced nonalcoholic steatohepatitis, Biochem Biophys Res Commun, 495, 1775, 10.1016/j.bbrc.2017.12.045

Rezazadeh, 2012, Amelioration of diet-induced nonalcoholic steatohepatitis in rats by Mn–salen complexes via reduction of oxidative stress, J Biomed Sci, 19, 26, 10.1186/1423-0127-19-26

Tariq, 2014, Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non‐alcoholic steatohepatitis (NASH)?, Liver Int, 34, e180, 10.1111/liv.12523

Leclercq, 2000, CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis, J Clin Investig, 105, 1067, 10.1172/JCI8814

Weltman, 1996, Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation, Gastroenterology, 111, 1645, 10.1016/S0016-5085(96)70028-8

Weltman, 1998, Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis, Hepatology, 27, 128, 10.1002/hep.510270121

Abdelmegeed, 2012, Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced nonalcoholic steatohepatitis, J Hepatol, 57, 860, 10.1016/j.jhep.2012.05.019